Access cutting-edge nasolacrimal duct obstruction treatment through this clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Nashville location
Preparing your pre-screening questions…
Access nasolacrimal duct obstruction specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nasolacrimal duct obstruction treatment provided free
Check if you qualify for this nasolacrimal duct obstruction clinical trial in Nashville, TN
No-Cost Study Care
Local to Nashville
Convenient for TN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The association of radioiodine therapy for the treatment of thyroid cancer with nasolacrimal duct obstruction has been well documented in the medical literature. Prior case reports have documented radioactive iodine detection in the tears of patients following radioiodine therapy. It is possible that radioactive uptake by the cells in the lacrimal sac and nasolacrimal duct lead to inflammation, fibrosis, and obstruction of the tear duct over time. A recent study has shown that the administration of artificial tears decreases the level of detectable radioiodine in the tears of patients undergoing radioiodine therapy for thyroid cancer. The purpose of this study will be to assess whether administering tears after radioactive iodine therapy for thyroid cancer decreases the incidence of nasolacrimal duct obstruction in the two years following radioactive iodine treatment.
Sponsor: Vanderbilt University Medical Center
Yes, this clinical trial (NCT05999630) has an active research site in Nashville, TN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for nasolacrimal duct obstruction treatment options in Nashville, TN, this clinical trial (NCT05999630) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Nashville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasolacrimal duct obstruction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all nasolacrimal duct obstruction clinical trials near you to find additional studies recruiting in your area.
See all ulcerative colitis clinical trials recruiting in Nashville — not just this study.
Browse Ulcerative Colitis Trials in Nashville →